| Literature DB >> 26614801 |
Philippa Bowland1, E Ingham2, Louise Jennings2, John Fisher2.
Abstract
A review of research undertaken to evaluate the biomechanical stability and biotribological behaviour of osteochondral grafts in the knee joint and a brief discussion of areas requiring further improvement in future studies are presented. The review takes into consideration osteochondral autografts, allografts, tissue engineered constructs and synthetic and biological scaffolds. © IMechE 2015.Entities:
Keywords: Osteochondral graft; articular cartilage; biomechanics; biotribology; friction; knee; regeneration; scaffold; subchondral bone; tissue engineering
Mesh:
Year: 2015 PMID: 26614801 PMCID: PMC4676357 DOI: 10.1177/0954411915615470
Source DB: PubMed Journal: Proc Inst Mech Eng H ISSN: 0954-4119 Impact factor: 1.617
Overview of current surgical methods for the treatment of osteochondral defects in the knee.
| Surgical treatment | Advantages | Limitations |
|---|---|---|
| Arthroscopic debridement and lavage | Arthroscopic or minimally invasive | Progressive deterioration Recurring symptoms |
| Cost-effective | ||
| Short rehabilitation time | ||
| Microfracture or marrow stimulation | Cost-effective Surgically reproducible | Fibrocartilage formation |
| Partial defect filling | ||
| Functional deterioration after 18–24 months[ | ||
| Osteochondral autograft transplantation and mosaicplasty | Restoration of hyaline cartilage articulating surface Good chondrocyte survival rateGood clinical results at medium long-term follow-up[ | Lack of cartilage integration |
| Poor matching of graft and host cartilage congruency | ||
| Donor site morbidity | ||
| Limited tissue availability | ||
| Potential chondrocyte apoptosis during graft impaction[ | ||
| Osteochondral allograft transplantation | Restoration of hyaline cartilage articulating surface | Potential immunological response and disease transmission |
| Treatment of large defects | Limited graft availability | |
| Good long-term clinical results and graft survival[ | Potential chondrocyte apoptosis during graft impaction[ | |
| Autologous chondrocyte implantation (ACI) and matrix-assisted ACI (MACI) | Arthroscopic or minimally invasivePotential for hyaline cartilage repair tissue Use of autologous cells | Expensive |
| Two-stage procedure | ||
| Variable repair tissue type: hyaline like, fibrocartilage and mixed[ | ||
| Limited defect filling and integration[ |
Overview of materials commonly used in the development of regenerative osteochondral scaffolds.[14–17]
| Scaffold classification | Material |
|---|---|
| Natural polymers | Collagen |
| Gelatin | |
| Fibrin | |
| Hyaluronic acid | |
| Alginate | |
| Agarose | |
| Chitosan | |
| Silk | |
| Synthetic polymers | Poly(ethylene glycol) (PEG) |
| Poly(caprolactone) (PCL) | |
| Poly(lactic acid) (PLA) | |
| Poly(glycolic acid) (PGA) | |
| Poly(lactic- | |
| Bioceramics | Bioactive glasses |
| Hydroxyapatite | |
| Calcium phosphates | |
| Extracellular matrix | Decellularised and devitalised cartilage and bone tissue |
| Combination of scaffolds | Combination of materials as stated above |
Figure 1.Schematic diagram of osteochondral graft and defect hole geometries: (a) bottomed graft (osteochondral graft and defect hole of equal length) and (b) unbottomed graft (osteochondral graft shorter in length than defect hole).
Figure 2.Schematic diagram of possible outcomes following osteochondral graft implantation: (a) ideal implantation scenario for restoring congruent articular surface, (b) osteochondral graft implanted proud of host articular cartilage surface, (c) osteochondral recessed below host cartilage surface and (d) no osteochondral graft implanted into defect.